Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed Lamkanfi

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Nature Reviews. Immunology|February 26, 2011
Emerging inflammasome effector mechanismsMohamed Lamkanfi
Molecular Aspects of Medicine|June 13, 2022
The human inflammasomesOonagh Paerewijck, Mohamed Lamkanfi
Immunological Reviews|January 4, 2025
MAP Kinase Signaling at the Crossroads of Inflammasome ActivationAlex Vervaeke, Mohamed Lamkanfi
Rheumatology (Oxford, England)|December 23, 2022
Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3Lieselotte Vande Walle, Mohamed Lamkanfi
The International Journal of Biochemistry & Cell Biology|January 19, 2010
Nlrp3: an immune sensor of cellular stress and infectionMohamed Lamkanfi, Thirumala-Devi Kanneganti
The Journal of Experimental Medicine|October 25, 2017
A new lead to NLRP3 inhibitionMohamed Lamkanfi, Vishva M Dixit
Immunity|July 17, 2009
IL-33 raises alarmMohamed Lamkanfi, Vishva M Dixit
Immunity|July 16, 2020
Snapshot of a Deadly Embrace: The Caspase-1-GSDMD InterfaceLieselotte Vande Walle, Mohamed Lamkanfi
Cell Host & Microbe|July 20, 2010
Manipulation of host cell death pathways during microbial infectionsMohamed Lamkanfi, Vishva M Dixit
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2011
Modulation of inflammasome pathways by bacterial and viral pathogensMohamed Lamkanfi, Vishva M Dixit
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Nature Reviews. Immunology|February 26, 2011
Emerging inflammasome effector mechanismsMohamed Lamkanfi
Molecular Aspects of Medicine|June 13, 2022
The human inflammasomesOonagh Paerewijck, Mohamed Lamkanfi
Immunological Reviews|January 4, 2025
MAP Kinase Signaling at the Crossroads of Inflammasome ActivationAlex Vervaeke, Mohamed Lamkanfi
Rheumatology (Oxford, England)|December 23, 2022
Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3Lieselotte Vande Walle, Mohamed Lamkanfi
The International Journal of Biochemistry & Cell Biology|January 19, 2010
Nlrp3: an immune sensor of cellular stress and infectionMohamed Lamkanfi, Thirumala-Devi Kanneganti
The Journal of Experimental Medicine|October 25, 2017
A new lead to NLRP3 inhibitionMohamed Lamkanfi, Vishva M Dixit
Immunity|July 17, 2009
IL-33 raises alarmMohamed Lamkanfi, Vishva M Dixit
Immunity|July 16, 2020
Snapshot of a Deadly Embrace: The Caspase-1-GSDMD InterfaceLieselotte Vande Walle, Mohamed Lamkanfi
Cell Host & Microbe|July 20, 2010
Manipulation of host cell death pathways during microbial infectionsMohamed Lamkanfi, Vishva M Dixit
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2011
Modulation of inflammasome pathways by bacterial and viral pathogensMohamed Lamkanfi, Vishva M Dixit
Pageof 16